Futuximab
- Generic Name
- Futuximab
- Drug Type
- Biotech
- CAS Number
- 1310460-85-5
- Unique Ingredient Identifier
- B37J680LX0
- Background
Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath